|
18 Companies |
|
18 Products |
|
18 Products |
|
16 Mechanisms of Action |
|
0 Trials |
|
204 News |
|
| «1234 |
- ||||||| Adacel (tetanus toxoid/reduced diphtheria toxoid/acellular pertussis vaccine adsorbed) / Sanofi, Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Trial completion: Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old (clinicaltrials.gov) - Oct 10, 2011
P3, N=954, Completed, Sponsor: Sanofi Pasteur MSD
Active, not recruiting --> Completed
- ||| Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and hemophilus b conjugate) / Sanofi
Enrollment change: Immunogenicity and Safety of TETRAXIM (clinicaltrials.gov) - Oct 3, 2011
P4, N=123, Completed, Sponsor: Sanofi
Active, not recruiting --> Completed N=167 --> 123
- dalfampridine / Generic mfg.
New P4 trial: Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (clinicaltrials.gov) - Oct 3, 2011
P4, N=8, Terminated, Sponsor: Johns Hopkins University
- |||| Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and hemophilus b conjugate) / Sanofi
Trial completion: Immunogenicity and Safety of TETRAXIM (clinicaltrials.gov) - Oct 3, 2011
P4, N=123, Completed, Sponsor: Sanofi
N=167 --> 123 Active, not recruiting --> Completed
- |||||||||| Hexaxim (DTaP-IPV-Hep B-Hib vaccine) / Sanofi
New P3 trial, IO biomarker: Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa (clinicaltrials.gov) - Sep 29, 2011
P3, N=1106, Completed, Sponsor: Sanofi Pasteur, a Sanofi Company
- | Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
Trial completion: Safety and Tolerability of Rituximab in Neuromyelitis Optica (clinicaltrials.gov) - Sep 25, 2011
P1, N=20, Completed, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Infanrix (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed) / GSK
Trial completion: Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers (clinicaltrials.gov) - Sep 21, 2011
P3, N=957, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Active, not recruiting --> Completed